MJBizCon attendees prepare to tackle marijuana industry challenges in 2023
As the regulated marijuana industry wraps up the 2022 business year, companies are fine-turning their strategies for whatever new challenges 2023 might bring.
In historic first, Congress passes medical marijuana research bill
The U.S. Senate approved bipartisan legislation that would ease restrictions on medical marijuana-related research, sending to President Joe Biden’s desk the first of what the cannabis industry hopes is a flurry of MJ-related bills over the next month.
Opinion: Using science to create a winning marijuana industry
It’s important not only to identify constraints but also think of ways to overcome them. Here are five ways the cannabis industry can do that.
New York eases marijuana testing requirements for some contaminants
New York regulators have eliminated marijuana testing limits for contaminants bacteria, mold and yeast after outdoor cannabis cultivators complained that the original rules were too restrictive.
Moldy, untested cannabis flower recalled in Colorado’s second-largest city
Nearly 200 of batches of cannabis flower – some more than a year old – have been recalled after Colorado regulators discovered “potentially unsafe levels of total yeast and mold,” including the fungus aspergillus.
Pennsylvania’s final medical marijuana rules include disputed testing change
Pennsylvania regulators approved the final regulations for the state’s medical marijuana market, which was established in 2016.
Nevada marijuana lab disciplinary hearing further highlights industry’s testing woes
Nevada is the latest state to crack down on marijuana testing labs in yet another example of the cannabis industry’s increasing awareness of problems related to potency and contaminant testing.
